SINTX Technologies Says Study Shows Silicon Nitride Effective Against Virus Strains; Shares Rise
MT Newswires Live
Sep 03, 2025
SINTX Technologies (SINT) said Wednesday it has published a peer-reviewed study demonstrating that silicon nitride exhibits potent antiviral activity against multiple infectious virus strains, including SARS-CoV-2 and MERS-CoV.
The study showed that direct contact to alpha-phase silicon nitride reduced infectious SARS-CoV-2 titers by up to 99.97% within 10 minutes and achieved complete inactivation after 30 minutes, SINTX said.
The study also showed 97% inactivation with contact to silicon nitride when embedded in fabric used in medical devices, the company said.
Shares of SINTX, a silicon nitride manufacturer, were 24% higher in premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.